Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bafadhel, S. McKenna, S. Terry, V. Mistry, C. Reid, M. McCormick, P. Rugman, M. Jenkins, P. Dodson, P. Newbold, M. Saunders, C. Brightling (Leicester, Loughborough, United Kingdom). The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2010; 36: Suppl. 54, 5500

Member's Comments

No comment yet.

Related content which might interest you: Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Small airway inflammation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001 Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016 Year: 2017 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 The importance of eosinophilic inflammation in COPD exacerbations Source: International Congress 2017 – COPD management Year: 2017 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Disease of the airways in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 41S-49S Year: 2001 Definition and differential diagnosis of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1 Year: 2006 Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Modulation of airway inflammation to prevent exacerbations of COPD Source: Eur Respir Rev 2005; 14: 78-82 Year: 2005 A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005